Actively Recruiting
Evaluating Safety and Performance of the ProGYNious Pelvic Floor Mesh Implant for Laparoscopic Sacrocolpopexy in Women with Pelvic Organ Prolapse
Led by A.M.I. Agency for Medical Innovations GmbH · Updated on 2026-10-30
100
Participants Needed
4
Research Sites
12 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and effectiveness of the ProGYNious mesh implant to treat pelvic organ prolapse in women. This prospective international study involves multiple medical centers and aims to verify treatment success, safety, potential risks, complications, and quality of life after using the mesh implant in laparoscopic sacrocolpopexy. The ProGYNious device is a Y-shaped synthetic mesh made of two types of polypropylene with different properties. It features an ultra-light monofilament mesh body with a highly elastic pore structure and a reinforced mesh neck for strong fixation to the sacral promontory. Participants receive laparoscopic surgery to implant the device and are followed post-operatively to assess outcomes. Participants will be monitored at 3 and 12 months after surgery through clinical examinations measuring prolapse cure rates, complications, adverse events, anatomical outcomes POP-Q, quality of life, sexual function, and subjective success. The study collects data to ensure thorough evaluation of treatment impact and safety over this follow-up period.
CONDITIONS
Brief Title
Safety and Performance of a Pelvic Floor Mesh Implant for Laparoscopic Sacrocolpopexy (ProGYNious)
Research Team
F
Florian Blab, MA
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here